BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
Effect of Aprotinin on Transfusion Requirements and Blood Loss in Patients Undergoing Elective Primary Total Hip Replacement
Phase 3
Completed
- Conditions
- Blood Loss, Surgical
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-04-28
- Last Posted Date
- 2014-12-30
- Lead Sponsor
- Bayer
- Target Recruit Count
- 359
- Registration Number
- NCT00668031
Assess Efficacy of Vardenafil 10mg in Erectile Dysfunction Within Intake of 6 Hours
- First Posted Date
- 2008-04-28
- Last Posted Date
- 2014-12-23
- Lead Sponsor
- Bayer
- Target Recruit Count
- 887
- Registration Number
- NCT00668018
Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or Hyperlipidemia
Phase 3
Completed
- Conditions
- Erectile Dysfunction
- Interventions
- First Posted Date
- 2008-04-28
- Last Posted Date
- 2014-12-23
- Lead Sponsor
- Bayer
- Target Recruit Count
- 614
- Registration Number
- NCT00668109
Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction and Hypertension
Phase 3
Completed
- Conditions
- Erectile Dysfunction
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-04-28
- Last Posted Date
- 2014-12-16
- Lead Sponsor
- Bayer
- Target Recruit Count
- 388
- Registration Number
- NCT00668005
PK in Pts With HRPC & Skeletal Metastes
Phase 1
Completed
- Conditions
- Prostatic Neoplasms
- Interventions
- First Posted Date
- 2008-04-28
- Last Posted Date
- 2015-12-14
- Lead Sponsor
- Bayer
- Target Recruit Count
- 6
- Registration Number
- NCT00667537
Ciprofloxacin on Burned Patients
- First Posted Date
- 2008-04-28
- Last Posted Date
- 2009-10-27
- Lead Sponsor
- Bayer
- Target Recruit Count
- 18
- Registration Number
- NCT00668044
Efficacy and Safety of CIPRO XR Versus CIPRO IR in Patients With Complicated Urinary Tract Infections
Phase 3
Completed
- Conditions
- Urinary Tract Infection
- Interventions
- First Posted Date
- 2008-04-28
- Last Posted Date
- 2009-06-30
- Lead Sponsor
- Bayer
- Target Recruit Count
- 212
- Registration Number
- NCT00668122
Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to Intercourse
Phase 4
Completed
- Conditions
- Erectile Dysfunction
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-04-28
- Last Posted Date
- 2009-06-30
- Lead Sponsor
- Bayer
- Target Recruit Count
- 264
- Registration Number
- NCT00667979
Assess Efficacy in Subjects With Traumatic Spinal Cord Injury
Phase 4
Completed
- Conditions
- Spinal Cord InjuryErectile Dysfunction
- Interventions
- First Posted Date
- 2008-04-28
- Last Posted Date
- 2015-05-06
- Lead Sponsor
- Bayer
- Target Recruit Count
- 45
- Registration Number
- NCT00667966
A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With Similar Therapy.
Phase 4
Completed
- Conditions
- Erectile Dysfunction
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-04-28
- Last Posted Date
- 2014-12-25
- Lead Sponsor
- Bayer
- Target Recruit Count
- 260
- Registration Number
- NCT00668096